Author’s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

Kioa Lente Wijnsma; Rob ter Heine; Jack F.M. Wetzels; Nicole C.A.J. van de Kar; Roger J. Brüggemann

doi:10.1007/s40262-020-00952-5

Author’s Reply to Liu et al. “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

Kioa Lente Wijnsma
, Rob ter Heine
, Jack F.M. Wetzels
, Nicole C.A.J. van de Kar
, Roger J. Brüggemann

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1645-1646
Number of pages	2
Journal	Clinical Pharmacokinetics
Volume	59
Issue number	12
DOIs	https://doi.org/10.1007/s40262-020-00952-5
Publication status	Published - Dec 2020
Externally published	Yes

Access to Document

10.1007/s40262-020-00952-5

Cite this

@article{28466b8a6a424e2ab985534a35904d90,

title = "Author{\textquoteright}s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”",

author = "Wijnsma, \{Kioa Lente\} and \{ter Heine\}, Rob and Wetzels, \{Jack F.M.\} and \{van de Kar\}, \{Nicole C.A.J.\} and Br{\"u}ggemann, \{Roger J.\}",

year = "2020",

month = dec,

doi = "10.1007/s40262-020-00952-5",

language = "English",

volume = "59",

pages = "1645--1646",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis",

number = "12",

}

Author’s Reply to Liu et al. “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”. / Wijnsma, Kioa Lente; ter Heine, Rob; Wetzels, Jack F.M. et al.
In: Clinical Pharmacokinetics, Vol. 59, No. 12, 12.2020, p. 1645-1646.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Author’s Reply to Liu et al.

T2 - “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

AU - Wijnsma, Kioa Lente

AU - ter Heine, Rob

AU - Wetzels, Jack F.M.

AU - van de Kar, Nicole C.A.J.

AU - Brüggemann, Roger J.

PY - 2020/12

Y1 - 2020/12

UR - https://www.scopus.com/pages/publications/85094112374

U2 - 10.1007/s40262-020-00952-5

DO - 10.1007/s40262-020-00952-5

M3 - Letter

C2 - 33118148

AN - SCOPUS:85094112374

SN - 0312-5963

VL - 59

SP - 1645

EP - 1646

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 12

ER -